Home LiteratureArticle Details
PMID: 25278611 Published · ppublish English

Prostate cancer. Ubiquitylome analysis identifies dysregulation of effector substrates in SPOP-mutant prostate cancer.

Science (New York, N.Y.) ·Vol. 346 ·No. 6205 ·2014-10-21

Theurillat Jean-Philippe P, Udeshi Namrata D, Errington Wesley J, Svinkina Tanya, Baca Sylvan C, Pop Marius, Wild Peter J, Blattner Mirjam, Groner Anna C, Rubin Mark A, Moch Holger, Privé Gilbert G, Carr Steven A, Garraway Levi A

Abstract

Cancer genome characterization has revealed driver mutations in genes that govern ubiquitylation; however, the mechanisms by which these alterations promote tumorigenesis remain incompletely characterized. Here, we analyzed changes in the ubiquitin landscape induced by prostate cancer-associated mutations of SPOP, an E3 ubiquitin ligase substrate-binding protein. SPOP mutants impaired ubiquitylation of a subset of proteins in a dominant-negative fashion. Of these, DEK and TRIM24 emerged as effector substrates consistently up-regulated by SPOP mutants. We highlight DEK as a SPOP substrate that exhibited decreases in ubiquitylation and proteasomal degradation resulting from heteromeric complexes of wild-type and mutant SPOP protein. DEK stabilization promoted prostate epithelial cell invasion, which implicated DEK as an oncogenic effector. More generally, these results provide a framework to decipher tumorigenic mechanisms linked to dysregulated ubiquitylation.

Article Info
Journal
Science (New York, N.Y.)
Abbr.
Science
Published
2014-10-21
Indexed
2014-10-03
Updated
2016-11-25
Language
English
Country/Region
United States
NLM ID
0404511
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]